The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Have to Like the Risk/Reward in Antigenics Stock

 Sep 27, 2009 08:30 AM UTC
Return Risk
-11.17% HIGH
Tracked Blogger
Symbol Sentiment Start Return Closed
AGEN n/a

Graphic_arrow1 Via Long Investment Ideas from Seeking Alpha:  

Nothing has changed with the potential of Antigenics (AGEN) and its stock. If anything, the longer it trades for a price of near two dollars, the better buy it becomes because the closer news is to being released.

Investors have heard nothing that would lead us to believe that the fourth quarter Oncophage launch in Russia is not moving along as planned - it's still only a final decision on the Russian Government reimbursement that we're waiting on.


 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch